Regulation on application of integration …...integration testing and debugging of software...
Transcript of Regulation on application of integration …...integration testing and debugging of software...
Regulation on application of integration environment – FGIS MDLP Sandbox-integrated OMS/test environment OMS
Moscow 2019
2
Introduction
1. Document purpose
This document describes the order for integration testing of software solutions developed by the integrators
in the following environments of Operator-CRPT LLC:
1. integration environment - FGIS MDLP Sandbox-integrated OMS
2. test environment OMS (no integration with FGIS MDLP Sandbox)
All actions in these environments do not have a legal value and performed exclusively for the purpose of
integration testing and debugging of software solutions developed by the integrators for pharmaceutical entities.
2. Document objectives
2.1. Development of the unified approach for application of the integration/test environment;
2.2. Determination of integration testing stages (hereinafter - integration testing) for software solutions
developed by the integrators with a link to FGIS MDLP-integrated OMS/test OMS;
2.3. Determination of the order for notifying the integrators on scheduled and unscheduled maintenance for
the integration environment - FGIS MDLP Sandbox-integrated OMS;
2.4. Familiarization of the integrators with the work on actual updates in releases of FGIS MDLP, OMS.
3. Terms and abbreviations
GTIN – Global Trade Item Number — goods barcode
SGTIN
SNTIN
–
–
Serialised Global Trade Item Number - goods serial number consisting of GTIN
and the serial number proper
Serialised Notional Trade Item Number is the full marking number, including
SGTIN, verification code (crypto tail) and application identifiers.
BO – business order for marking codes
FGIS MDLP Sandbox – the test version (“Sandbox”) of the Medicine track and trace government
information system
Integrator – the organization developing software solutions for integration of automated
process control systems for pharmaceutical entities with a link to FGIS MDLP-
OMS
Integration
environment
– test versions set of information systems intended for simulation of processes
identical to the productive environment that do not have a legal value and
performed for testing/debugging the integration with the software of
pharmaceutical entities
Marking code, MC – a unique sequence of characters including a Serialised Global Trade Item
Number and a verification code
UA – user account
PA – personal account
3
Productive environment – a set of productive (“live”) versions of information systems intended for
implementation of processes with a legal value
Identification means, IM – marking code represented in machine-readable form or using another means
(technology) of automated identification generated for application on a
package by the methods that do not allow undamaged separation of
identification means and (or) material mediums containing the identification
means from a medicine package.
OMS – Order Management Station
EDMS – electronic document management system
RC – registration certificate
RF – the Russian Federation
GG
Test environment OMS
–
–
goods group
test version of the Order Management Station (OMS) intended for simulation
of processes that are identical to the productive environment, do not have legal
value and are performed to test/debug the integration with the software of
pharmaceutical entities. This environment is not integrated with FGIS MDLP
Sandbox.
EQES – enhanced qualified electronic signature
Pharmaceutical entity – an entity of the medicine turnover, a legal entity or an individual entrepreneur
performing the turnover of medicines in the Russian Federation.
Note: under this document the “pharmaceutical entity” and “integrator” terms
can be used as equivalents since the integrator is not a pharmaceutical entity
but performs in the integration environment the activities for
testing/debugging of own software solutions as a pharmaceutical entity
4
Description of integration process testing
4. Content of integration process testing
The integration testing process includes the following basic1 sub-processes:
integrator’s request for registration in one of the environments of Operator-CRPT LLC;
business order creation and application of identification means via OMS interface;
business order creation and application of identification means via OMS API;
payment for marking codes.
The content of the integration testing process can be modified and supplemented by Operator-CRPT LLC.
5. “Integrator’s request for registration in the integration environment” sub-process;
5.1. The integration environment of FGIS MDLP Sandbox – integrated OMS is configured for connectivity of
these systems, which allows debugging/testing the entire commodity distribution chain, including the
issuance of marking codes, their receipt and sending of reports on application of marking codes by means
of OMS. This will be followed by the verification of availability and correctness of reports, SGTINs in FGIS
MDLP Sandbox.
5.2. The access to integration environment (FGIS MDLP Sandbox + integrated OMS) can be provided only to
the Integrator.
The access to OMS in the integration environment can be provided to the pharmaceutical entity, if such
entity has access to the user account in FGIS MDLP Sandbox, in which the participant registers on its own
by submitting the request to https://sb.mdlp.crpt.ru/#/auth/signup/.
5.3. To initiate the process of registration in the integration environment it is required to send a request to
The email with the request shall have the following subject: The request for access to the Pharma
integration environment
The request shall specify the following data:
INN/ITIN
OGRN/OGRNIP
Organization name
Registration number in FGIS MDLP Sandbox (to be specified if UA in FGIS MDLP Sandbox is available)
Type of participant: Integrator
Type of access: for a resident/non-resident of RF (one option shall be specified)
Last name, first name, patronymic (if any) of the contact person
Contact phone
Environment: Pharma integration environment
List the medicines manufacturers that you represent as the Integrator
5.4. The GG makes a decision on provision or denial to provide the access to the integration environment;
1Basic sub-processes mean sub-processes, without the performance of which the integration environment cannot be accessed as well as the process of issuing MCs and sending the report on their application.
5
5.5. In the event of a negative decision, the Integrator is notified of the access denial via email from
5.6. In case of incomplete data provided in the request, the Integrator can be requested missing data;
5.7. During the registration in the integration environment to perform the testing the following test (fictive)
entities/data can be created/specified in the FGIS MDLP Sandbox UA:
INN/ITIN
OGRN/OGRNIP
KPP
license number for pharmaceutical activity
license number for medicine production;
setting of “7VZN” attribute for a pharmaceutical entity (for residents of RF);
medicines (GTIN) with 7VZN attributes (for residents of RF), VED (for residents of RF) and without
the attribute (for residents and non-residents of RF);
business place;
safe storage place;
contract on service for marking codes provision (for residents of RF);
the personal account of entity replenished with funds (or residents of RF)
entity’s accounting systems;
EQES certificate (pfx format) to login the UA in the MDLP FGIS (for residents)
5.8. During the registration in the integration environment the test emission registrar (hereinafter - ER)
connects to the integrated OMS to perform testing;
5.9. Once the registration2 completed, a pharmaceutical entity is notified of access granting to the integration
environment and provided with the login account data via [email protected].
5.10. When registering as the resident of the Russian Federation, Operator-CRPT LLC provides the test EQES
certificate for the Integrator. Once the provided certificate expired, you need to contact the technical
support service to re-issue it.
For this purpose, proceed as follows:
send an email with the subject “Integrator. Re-issue of EQES test certificate”;
attach to the letter the expired EQES certificate;
specify in the email the name of your organization (from the UA in “Sandbox” MDLP FGIS) and the
registration number from the UA in “Sandbox” MDLP FGIS.
6. The "Submitting a request for registration in the test environment OMS" sub-process
6.1. The test environment OMS does not have connectivity with FGIS MDLP Sandbox. This environment is
intended for testing and debugging the direct interactions with OMS (UI/API).
2 If access is granted to two systems: FGIS MDLP Sandbox and CPS-integration, then a notification is sent to the participant after registration is completed in both systems
6
6.2. The access to the test environment OMS can be provided both to the Integrator and the pharmaceutical
entity.
6.3. To initiate the registration process in the test environment OMS, it is necessary to submit a request to
The message with the request should include the following in the subject line: Request for access to the
test environment OMS Pharma
The request must include the following data:
INN/ITIN
Organization name
Registration number in FGIS MDLP Sandbox (indicate, if there is a user account in FGIS MDLP
Sandbox)
Type of pharmaceutical entity: Integrator/Pharmaceutical entity
Access type: for resident of the Russian Federation/for non-resident of the Russian Federation
(highlight only one)
Last name, first name, patronymic (if any) of the contact person
Contact telephone number
Environment: test environment OMS
List the manufacturers of medicinal products that you represent as an Integrator (only for the type
of pharmaceutical entity: Integrator)
6.4. In the case of incomplete data submitted in the request, the Integrator/pharmaceutical entity may be
requested to provide missing data;
6.5. During the registration in the test environment for the purpose of testing, OMS will be connected to the
test ER;
6.6. Following the completion of the registration process, the Integrator/pharmaceutical entity is notified on
the provision of access to the test environment OMS and receives an email with account details sent from
7. “Business order creation and application of identification means via OMS interface” sub-process;
Preconditions:
The pharmaceutical entity is registered in the integration environment/test environment OMS
The pharmaceutical entity is provided with the test ER
Funds are credited to the personal account of the pharmaceutical entity (available funds on the
pharmaceutical entity’s PA is obligatory for order of charged MC)
In order to test the procedure for business order creation and application of identification means via
OMS interface, the following actions shall be performed in sequence:
7
7.1. Login FGIS MDLP Sandbox (to be performed for the integration environment)
On the FGIS MDLP Sandbox login page click “Sign in with certificate” button and login by means of test
EQES (for residents of the Russian Federation) or log in using your login and password (for non-residents
of the Russian Federation);
7.2. Redirect to the Order Management Station (to be performed for the integration environment)
7.2.1. Redirect to the “Profile” section then click the “SGTIN Order” button.
7.2.2. When clicking the “SGTIN Order” button, FGIS MDLP Sandbox automatically
redirects the user to the Order Management Station interface (OMS), “Business orders”
section, the OMS login is performed with the Operator account.
7.3. Authorization in OMS (to be performed for the test environment OMS)
On the authorization page of OMS, enter your login and password specified in the email received
following the provision of access to OMS and press Enter.
7.4. Business order creation
The business order creation process can be tested with link to the marking codes payment process
described in clause 9 of this document, if all preconditions in clause 9 of this document are fulfilled.
8
7.4.1. The “Create” button shall be clicked to create a business order.
7.4.2. The interface displays the order creation form.
The following fields shall be filled in (the requirement to fill in the field is determined by
the order creation form):
Field name Filling in rule
Step 1. General data
Entity To be filled in with the registration number of the pharmaceutical entity
from the Profile in FGIS MDLP Sandbox
Payment indication The field is used to define the payment criteria for marking codes.
The “payable” value shall be selected for the medicines that selling price
exceeds 20 roubles.
The “not payable value shall be selected for the medicines that selling
price does NOT exceed 20 roubles.
Payment type The field is used to select the type of payment for marking codes. The
field is mandatory if the “Payment criteria” field has the “MC payable”
value.
At payment upin application the funds are debited from the
pharmaceutical entity’s PA upon the receipt of MC application report by
9
FGIS MDLP Sandbox (10311 form (residents of RF)/10319 form (non-
residents of RF).
At payment upon emission the funds on the pharmaceutical entity’s PA
are reserved at the moment of BO sending, and debited upon the receipt
of MC emission report by FGIS MDLP Sandbox (10300 form).
Step 2. Goods (you can go to Step 2 by pressing Go to goods)
Goods code To be filled in with the GTIN number for which the BO is generated.
MC quantity To be filled in with a required number of IM
Identification codes
template
The field is used to select the length (number of characters) of verification
code
Serial number
generation method
The field is used to select the serial number generation method
At the automatically method, serial numbers are generated by OMS
At the by user method, it is required to upload to OMS a csv-file containing
serial numbers generated by the pharmaceutical entity. For this purpose,
the “Upload CSV” button will be displayed in the interface.
Using this serial number generation method, the “List of serial number”
filed is filled in automatically with several serial numbers in the file.
The file must contain unique serial numbers (SGTINs) that were not used
by the pharmaceutical entity when creating orders. Otherwise, OMS will
generate an error.
7.4.3. Once the business order form is completed, the Save button shall be clicked. Once
this button is clicked, the order confirmation form will be displayed in the interface (the
sub-process of MC payment is described in clause 9 of this document). If all order
parameters are entered correctly it is required to check the box: “I confirm the
correctness of the entered data” and click the “Send request” button.
10
7.4.4. Clicking this button initiates the business order sending for verification and its further
generation. Once the order is assigned with “Available” status, the receipt of marking codes
can be started.
You can read more on the status model of orders for marking codes in the specification of OMS API
posted on the official website at https://chestnyznak.ru/en/. In the Medications section , go to
"Documents for MDLP", then go to "To developers".
Upon receipt of the “Available” status by the order, the report “10300-Issue of Marking Codes” is
automatically generated and sent to the MDLP FGIS Sandbox.
7.5. Receiving the marking codes
7.5.1. To receive the marking codes as well as to view the detailed information on the
order/commodity, click the order ID. This will open the order form consisting of 2 tabs:
General data and Goods.
To obtain the marking codes, go to the Goods tab and click icon on the right in the
commodity line.
7.5.2. This will open the form for obtaining the marking codes.
Fill in the following fields (the requirement to fill in the fields is determined by the form for
obtaining MCs):
Field names Filling in rule
Format Format of the file, in which the printed marking codes are placed
Template Template of the label, on which it is necessary to print the marking codes
Quantity This indicates the number of MCs to print
7.5.3. After filling in all fields, press the Print button. This will initiate the download of the
file with marking codes to the user browser.
7.5.4. When printing, marking codes are converted to identification means. From one
order it is possible to print the number of codes that does not exceed the number
specified at the order generation. The ordered number of marking codes is shown in
“Total codes” fields on the "Goods" tab.
The number of already printed marking codes is shown in the “Received” field.
The number of codes available for printing is displayed in the “Codes in buffer” field.
11
7.6. Sending a report on using (applying) the marking codes.
7.6.1. To create and send the report, go to the Application section.
7.6.2. Pressing button opens the form of report on application. In the form of
report, the General data block indicates the following read-only data:
commodity group of pharmaceutical entity – Medicines for medical use
type of marking code usage – Application of MC verified.
In this form, fill in the following fields (the requirement to fill in the fields is determined by the
form of report on application):
Field name Filling in rule
Expiry date Expiry date of a marked medicine shall be specified
Production order
type
Production order type shall be specified (own or contract production),
this field is filled in only if the medicinal product is manufactured within
the Russian Federation
Business place ID At medicine production in RF: 14-character identifier of the entity
business place as per the license, assigned upon the business place
registration by the entity in FGIS MDLP Sandbox
At medicine production outside RF. When the medicinal product is
manufactured outside the Russian Federation: 36-character number is
assigned to the holder of the registration certificate (or its
representative) upon its registration in FGIS MDLP Sandbox
Owner ID To be filled in with an owner registration number in RC (foreign
contractor) from “Foreign contractors register” section in FGIS MDLP
Sandbox if the “Production order type” has the “Contract production”
value
Production series
number
The production series number of the marked medicine shall be specified
ID of the producer
that performed
To be filled in with a registration number of a producer that performed
packing/prepacking in secondary (tertiary) package (foreign contractor)
12
packing/prepacking
in the
secondary/tertiary
packaging
from “Foreign contractors register” section in FGIS MDLP Sandbox, if the
medicinal product is manufactured outside the Russian Federation.
ID of the producer
that performed
release quality
control
To be filled in with a registration number of the producer that
performed the release quality control (foreign contractor) from “Foreign
contractors register” section in FGIS MDLP Sandbox. This field may be
filled in, if the medicinal product is manufactured outside the Russian
Federation.
This field is mandatory only if the medicinal products is marked in the
customs zone.
Identified of the
location of goods in
the customs control
zone
To be filled by 36-character identifier of commodity location from the
register of locations in the customs zone in FGIS MDLP. The field must
be filled in, if the medicinal products are marked in the customs zone.
Production date To be filled with the date and time of actual manufacturing of medicinal
product. This field is optional.
Attention! The date and time indicated in this field must not be earlier
than the issuance of marking codes. Otherwise, it will violate the history
of events.
Goods code Download csv file containing the applied SNTINs (full marking codes). To
do this, press
7.6.3. Once the form of report on marking codes printing form is completed, the “Print” button shall be
clicked. The list of reports in the Application section will display the saved report with Pending status.
7.6.4. To send the report, go to the Reports section.
All reports available for sending have Pending status. To send a report, tick the box in the line of
required report (you can select several reports simultaneously) or select the action Send without
signature.
13
Once these steps are completed, the report acquires Ready for sending status.
If the report was successfully sent, its status will change to Sent, “10311-Packing completion
(emission registrar)” reports for residents of RF / “10319-Medicine release outside RF (emission
registrar)” for non-residents of RF will be generated and sent to FGIS MDLP Sandbox.
In the case of an error when sending a report, the status will change to Rejected.
You can read more on the status model of reports in the specification of OMS API posted on the
official website at https://chestnyznak.ru/en/ In the section Medications, go to Documents for
MDLP, then go to To developers.
7.6.5. To view the detailed information on the report, click the icon of commodity group in the
Reports section. This will open the form of reports consisting of 2 tabs: General information and
Production.
The General information tab indicates the data included in the report when it was generated.
14
The Production tab indicates all marking codes included in the report on application.
15
Please note that on this tab the marking codes are indicated without the verification code (crypto
tail). The codes also include the usage identifiers: identifier "01" before the value of GTIN, identifier
"21" before the value of the serial number of medicinal product.
When searching for MC data in the user account of FGIS MDLP Sandbox, first remove the usage
identifiers from MC because FGIS MDLP Sandbox conducts the search by SGTIN.
7.7. Business order closure
7.7.1. Completely used orders are closed automatically. The number of active codes can not
exceed 100.
7.7.2. You can manually close the order with remaining unused marking codes by using various
methods. You can use any method from the list below:
In the order list press the Close order the order button in the required order line.
Go to detailed information about the order (by clicking the order identifier in the
list of orders), next click Close order.
Go to detailed information about the order (by clicking the order identifier in the
list of orders), next go to the Goods tab, click the Close button in the commodity
line.
16
This step will close the array (pool) of marking codes within the order. Since for
Pharma 1 the order can include only 1 commodity (GTIN), the order will be closed
automatically after closing the array (pool) of MCs.
7.7.3. To close the order (array of MCs), confirm this action by clicking the Close the order button
in the dialog box.
When you close the order in the integration environment, OMS will automatically generate and
send to FGIS MDLP Sandbox a report on rejected marking codes (scheme 10305 – Rejection), which
will include all MCs that remained unused in the order at the time of its closure.
7.7.4. Closed business orders disappear from the Active tab in the Orders section and are
displayed in the History of orders section.
8. “Business order creation and application of identification means via OMS API” sub-process
Preconditions:
The pharmaceutical entity is registered in the integration/test environment OMS
The pharmaceutical entity has information on omsId and clientToken
The pharmaceutical entity is provided with the test ER
Funds are credited to the personal account of the pharmaceutical entity (available funds in the
pharmaceutical entity’s PA is obligatory for the order of charged MC)
To test the procedure for business order creation and application of identification means via OMS API,
the following OMS API methods shall be called in sequence:
check OMS availability;
17
create a business order for marking codes emission;
receive the status of MC array from the business order;
receive the MC from the business order;
send a MC usage report;
close the sub-order for the specified GTIN. (This method is called when it is necessary to close an
order with unused marking codes. Fully used orders are closed automatically.)
The detailed description of OMS API methods, their calling procedure via OMS API to generate a business
order for marking codes as well as the description of transmitted parameters and response codes are set
forth in the documentation available on website http://chestnyznak.ru/en/ (“Medications” section, then
“Documents for MDLP”, then “To developers”)
9. “Payment for marking codes” sub-process (to be performed for integration environment)
Preconditions:
The pharmaceutical entity is registered in the integration environment
The pharmaceutical entity is a resident of RF;
The following medicines are registered in FGIS MDLP Sandbox:
- from the 7VZN list (the MC for the medicines that in FGIS MDLP Sandbox have “7VZN” attribute=Yes,
payable)
- from the VED list with selling price less than 20 roubles (the MC for the medicines included into the
VED list with selling price less than 20 roubles are not payable until 01.01.2020 and after 01.01.2020)
- from the 7VZN and VED lists with selling price less than 20 roubles (the MC for the medicines that in
FGIS MDLP Sandbox have “7VZN” attribute=No or “VED”=Yes, but their selling price more than 20
roubles, are not payable only until 01.01.2020)
The pharmaceutical entity is provided with the test ER
Funds are credited to the personal account of the pharmaceutical entity
To test the marking codes payment process, the following actions shall be performed in sequence:
9.1. Login FGIS MDLP Sandbox
9.1.1. On the FGIS MDLP Sandbox login page click “Sign in with certificate” button and
login by means of test EQES (for residents of the Russian Federation) or log in using your
login and password (for non-residents of the Russian Federation);
9.2. Redirect to the Order Management Station
9.2.1. Redirect to the “Profile” section then click “SGTIN Order” button.
18
9.2.2. When clicking the “SGTIN Order” button, FGIS MDLP Sandbox automatically
redirects the user to the Order Management Station interface (OMS), “Business orders”
section, the OMS login is performed with the Operator account.
9.3. Business order creation
9.3.1. Create the business order for marking codes as per clause 7.4 of this document.
9.3.2. Depending on the combination of values of “Payment criteria” and “Type of
payment” fields, the testing scenarios can be the following:
Payment indication=Payable
Payment type=Payment upon application
Means that the marking codes are ordered for a medicine that cost more than 20
roubles.
The pharmaceutical entity’s PA is to be debited after the receipt of identification means
application report by FGIS MDLP Sandbox: “10311-Packing completion (emission
registrar)” for residents of RF / “10319-Medicine release outside RF (emission
registrar)” for non-residents of RF.
At payment upon application the identification means shall be applied within 180 days
from the moment of display of this BO in the OMS UA of the pharmaceutical entity
(exact date and time are specified in “operation_date” attribute in “10300-Marking
codes emission” report).
After 180 days unused MC can no longer be printed.
Until July 1, 2020, the following form is displayed in the interface at confirmation of the
business order creation:
After July 1, 2020, the text in the dialog box for order confirmation will be changed for
the text that corresponds to paid marking codes.
Payment indication =Payable
Type of payment=Payment upon emission
Means that the marking codes are ordered for a medicine that cost more than 20
roubles.
The funds in the pharmaceutical entity’s PA are reserved when sending the business
order. If there are not enough funds in the personal account to create a reserve, the
19
operation is rejected. After verification for errors in the business order, the marking
codes are available for application. The reserved funds are debited from the
pharmaceutical entity’s PA upon the receipt of “10300-Marking codes emission” report
on the marking codes emission by FGIS MDLP Sandbox.
At payment upon emission the marking codes can be used without any time limit.
Until July 1, 2020, the following form is displayed in the interface at confirmation of the
business order creation:
After July 1, 2020, the text in the dialog box for order confirmation will be changed for the
text that corresponds to paid marking codes.
Payment criteria=Not payable
Means that the marking codes are ordered for a medicine that cost less than 20 roubles.
In this case, the “Type of payment” field value is not processed by the system.
The pharmaceutical entity's PA is not debited.
The marking codes can be used without any time limit.
Until July 1, 2020, At confirmation of the business order creation the following form is
displayed in the interface at confirmation of the business order creation:
NOTE: If the medicine selling price at the first shipment exceeds 20 roubles, the
following goods movement will be blocked until the marking codes are paid.
20
After July 1, 2020, the text in the dialog box for order confirmation will be changed for
the text that corresponds to free marking codes.
9.4. Verification of reports and payslips (to be performed for integration environment)
Availability of the reports on emission and marking codes application in the UA of a
pharmaceutical entity in FGIS MDLP Sandbox shall be verified.
9.4.1. Redirect to “Documents” section, click the “Sent” button. In the “Operation” filter
select one of the type of reports:
10300-Marking codes emission,
10311-Packing completion (emission registrar) – for residents of RF,
10319-Medicine release outside RF (emission registrar) – for non-resident of RF.
9.4.2. The report document and payslip can be downloaded by means of the buttons in
the right column of the report row.
The example of xml-report document “10300-Marking codes emission”
The example of xml-payslip document on operation “10300-Marking codes emission”
21
The example of xml-report document “10311-Packing completion (emission registrar)”
The example of xml-payslip document on operation “10311-Packing completion (emission
registrar)”
The example of xml-report document “10319-Medicine release outside RF (emission
registrar)”
22
The example of xml-payslip document on operation “10319-Medicine release outside RF
(emission registrar)”
9.4.3. Verification of SGTIN status
In the UA of pharmaceutical entity in FGIS MDLP Sandbox the SGTIN status from the order can
be verified. For this purpose, it is required to redirect to the “Goods” section, and then click the
“SGTIN register” button.
A particular SGTIN can be found using the filter.
23
NOTE: If the paid marking codes were ordered, but funds in the pharmaceutical entity’s PA are
not enough, all SGTINs from the order will be assigned with “Waiting for release, not paid”
status.
Free or paid SGTINs are assigned with “Waiting for release” status (for residents of RF) or
“Waiting for shipment in RF” (for non-residents of RF).
10. The order for notifying integrators on scheduled and unscheduled maintenance in the integration environment
The integrators are notified on maintenance in the integration environment via one of the below channels
or simultaneously via all channels.
The channel for notification is selected on the side of Operator-CRPT LLC depending on the type of
scheduled maintenance.
Notification channel Type of works
1. An email to the contact person
specified when requesting the
registration in the integration
environment from [email protected]
2. Telegram-channel “OMS-MDLP
notification”
Scheduled maintenance lasting more than
1 hour
Telegram-channel “OMS-MDLP notification”
Scheduled maintenance lasting more than
1 hour
Scheduled maintenance lasting less than 1
hour
Unscheduled maintenance
24
List of changes
Version Change date List of implemented changes
1.0 19.11.2019 Original document version
1.1 18.02.2020 Section 5. Sub-process “Request submission for the registration in the integrated environment by the Integrator”, clause 5.1:
The clause on the necessity to submit the EQES certificate by the Integrator, registering as the resident of the Russian Federation, is excluded from the request for the access to the “Pharma” integrated environment.
The new clause is added to the request for access to the “Pharma” integrated environment on the need to submit the data (organization name) on medicines manufacturers represented by the Integrator.
Section 5. Sub-process “Submission of the request for registration in the integrated environment by the Integrator”, section 5.6:
A “test EQES certificate” for test (simulated actions) is added by Operator-CRPT LLC to provide the quality assurance in the MDLP FGIS UA.
Section 5. Sub-process “Submission of the request for registration in the integrated environment by the Integrator”, clause 5.9 on re-issue of a test EQES certificate is added.
2.0 08.05.2020 In the document text, the interface screenshots were replaced with their
updated versions (corresponding to OMS 3.1.10 and higher).
Changed the numbering of sections.
Made changes to sections 1, 2 and 3: added the definition of test
environment OMS.
Section 6 . Added the sub-process "Submitting the request for registration
in the test environment OMS"
In the document text, added the clarifications on availability of sub-
processes in environment of Operator-CRPT LLC.